Skip to content

Post mastectomy radiotherapy among patients with T1-T2 1-3 node positive disease. A retrospective cohort study

Post mastectomy radiotherapy among patients with T1-T2 1-3 node positive disease. A retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024402
Enrollment
600
Registered
2021-02-05
Start date
2019-06-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiotherapy patients C50

Interventions

Group 1: All Breast Cancer patients presented from 1998 to 2018 who had Modified Radical Mastectomy with pathology result showing T1-T2 & 1-3 positive nodes who did receive Post mastectomy radiotherap

Sponsors

Aga Khan University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were 1) all Breast Cancer patients who had Modified Radical Mastectomy with pathology result showing T1-T2 &1-3 positive nodes who did or did not receive PMRT. 2) Pathology report confirming negative margins. 3) Complete record of oestrogen receptor (ER), progesterone receptor (PR) and human epithelial growth factor receptor (HER-2) status. 4) Number of excised nodes after axillary dissection in double digits i.e. > 10 nodes.

Exclusion criteria

Exclusion criteria: Incomplete medical records. Lost to follow up

Design outcomes

Primary

MeasureTime frame
Overall Survival in patients who did or did not receive radiotherapy postmastectomy in early breast cancer.

Secondary

MeasureTime frame
Disease free survival in patients who did or did not receive radiotherapy post mastectomy in early breast cancer.

Countries

Pakistan

Contacts

Public ContactDua Jabeen

Jinnah Sindh Medical University

jabeen_dua@hotmail.com+923212793106

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026